logo

For the Inventor, By the Inventor

Epsom, United Kingdom

Stephen Dudley Holmes

This inventor holds 16 USPTO granted patents, primarily in Monoclonal Antibodies. Top assignees: Smithkline Beecham Corporation, Glaxosmithkline LLC, Other. Active years: 1997-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephen Dudley Holmes. Retrieved from https://idiyas.com/inventor/stephen-dudley-holmes

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 16

% Patents Active = 81.3

Average Co-Inventor Count = 4.0

ph-index = 11

Forward Citations = 285(Granted Patents)


Location History:

  • Great Chishill, GB (2002)
  • Harlow, GB (2004 - 2006)
  • Epsom, GB (1997 - 2011)

Company Filing History:

goldMedal18 out of 2,198 
 
Smithkline Beecham Corporation
 patents
silverMedal2 out of 358 
 
Glaxosmithkline LLC
 patents
bronzeMedal3 out of 834,659 
Other
 patents
where one patent can have more than one assignee

Years Active: 1997-2011

Loading Chart...
Areas of Expertise:
Recombinant IL-5 Antagonists
Recombinant IL-4 Antibodies
Erythropoietin Receptor Antibodies
Tie2 Antagonist Antibodies
Tie2 Agonist Antibodies
M Protein
Monoclonal Antibodies
DNA Encoding
Therapeutic Disorders
16 patents (USPTO):Explore Patents
1. 7982005 - Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders (2011-07-19),
2. 7807793 - Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders (2010-10-05),
3. 7399837 - Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders (2008-07-15),
4. 6998124 - Erythropoietin receptor antibodies (2006-02-14),
5. 6946130 - Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders (2005-09-20),
6. 6706487 - Monoclonal antibody and the method of using the antibody (2004-03-16),
7. 6376653 - Tie2 antagonist antibodies (2002-04-23),
8. 6365154 - Tie2 agonist antibodies (2002-04-02),
9. 6358704 - M protein (2002-03-19),
10. 6129913 - Recombinant IL-5 antagonists useful in treatment of IL-5 mediated (2000-10-10),
11. 5928904 - DNA encoding recombinant IL4 antibodies useful in treatment of IL4 (1999-07-27),
12. 5914110 - Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders (1999-06-22),
13. 5882896 - M protein (1999-03-16),
14. 5851525 - Recombinant IL-5 antagonists useful in treatment of IL-5 mediated (1998-12-22),
15. 5693323 - Recombinant IL-5 antagonists useful in treatment of IL-5 mediated (1997-12-02),

Title: The Inventor Stephen Dudley Holmes: Pioneering Innovations in Epsom, GB

Introduction: Stephen Dudley Holmes is a distinguished inventor based in Epsom, GB, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Stephen Dudley Holmes holds several patents in the areas of renewable energy technologies, sustainable materials, and advanced medical devices, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, Stephen Dudley Holmes has established himself as a prominent figure in the innovation landscape, with numerous successful inventions that have had a significant impact on society.

Collaborations: Throughout his career, Stephen Dudley Holmes has collaborated with leading research institutions, universities, and companies to further develop and commercialize his inventions, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Stephen Dudley Holmes continues to push the boundaries of innovation, with his relentless pursuit of new ideas and solutions that have the potential to shape the future in meaningful ways.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…